Pharma Business - March 3, 2015
Novo Nordisk Adjusts IPO Price
Novo Nordisk is adjusting to the indicative offer price range for the initial public offering (IPO) of NNIT A/S on Nasdaq Copenhagen as further described in the offering circular, which was published on Feb. 23, 2015. According to the company, “The adjustment to the initial indicative offer price range reflects higher than expected investor demand for […]
Business article - March 2, 2015
SEC: Keep up With Compliance, Disclosures
Shoring up compliance and disclosure procedures is the best way for pharmaceutical companies to avoid brushes with regulatory agencies, according to the U.S. Securities and Exchange Commission (SEC). Andrew Ceresney, the SEC’s top enforcement director, delivered the message to attendees at the recent Annual Pharmaceutical Compliance Congress. Companies need to accurately report their dealings with […]
Business Award - March 1, 2015
BioFinland Prize to Biovian Oy
Turku-based bioindustry company Biovian Oy is this year’s winner of the BioFinland prize awarded by the Finnish Fair Foundation and Finnish Bioindustries FIB. The 12-year-old company specializes in biotechnology research and production. Biovian Oy provides services in the fields of biopharmaceuticals, contract manufacturing, analysis, process development and scaling and works with firms developing new pharmaceuticals. […]
Companies - February 27, 2015
AstraZeneca at Life Science Event
Danish biotech companies and scientists from the University of Copenhagen are invited to meet April 9 with BioPeople, the University of Copenhagen, the Capital Region and AstraZeneca Nordic Outreach to learn more about AstraZeneca’s areas of research focus and activities in the Danish and Nordic life science sector. Attendees also will have the chance to interact and […]
Collaboration - February 26, 2015
AstraZeneca, Orca Sign Pact
British biotech startup Orca got $122.5 million from AstraZeneca PLC after the two companies signed a three-year research agreement to develop Orca’s retinoic acid-related orphan nuclear receptor gamma inhibitors. Orca is slated to receive upfront and milestone payments from AstraZeneca, depending on the success of its RORϒ inhibitors in the program. There is potential for […]
Uncategorized - February 25, 2015
Could Saunas Reduce Heart Attack Risk?
Men who frequently use saunas had reduced risks of fatal cardiovascular events and mortality from other causes, according to an article published online by JAMA Internal Medicine. Jari A. Laukkanen, M.D., Ph.D., of the University of Eastern Finland, Kuopio, and coauthors investigated the connection between sauna bathing and the risk of SCD, fatal coronary heart disease (CHD), […]
